| id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S18637 R79205 |
Couto, 2015 | Acute lymphocytic leukemia - Children aged 0–23 months | 3 months (or more) before pregnancy or during pregnancy excluded | case control | unexposed (general population or NOS) | Adjustment: Yes Paracetamol use: maternal ITW/questionnaires after pregnancy |
0.56 [0.28;1.10] excluded (exposition period) |
17/77 74/259 | 91 | 77 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18626 R79160 |
Ognjanovic, 2011 | Acute lymphoblastic leukaemia - After knowledge of pregnancy - Any use | during pregnancy (anytime or not specified) | case control | unexposed (general population or NOS) | Adjustment: Yes Matched Paracetamol use: maternal ITW/questionnaires after pregnancy | 1.03 [0.70;1.53] | 181/407 80/174 | 261 | 407 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18774 R79881 |
Ross, 2003 | Leukemia (<18 months of age) | during pregnancy (anytime or not specified) | case control | unexposed (general population or NOS) | Adjustment: Yes Co-administration Matched Paracetamol use: maternal ITW/questionnaires after pregnancy Paracetamol use: prescription or medical files | 1.11 [0.41;2.98] | 8/19 235/617 | 243 | 19 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 2 studies | 1.04 [0.72;1.50] | 504 | 426 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Funnel plot not drawn. Less than 3 points.
Asymetry test p-value = NaN (by Egger's regression)
not enought points
Funnel plot not drawn. Less than 3 points.
excluded